glp-1 kidney protection GLP therapies have established themselves as kidney-protective in type 2 diabetes and high risk of disease. This new post-hoc analysis of SURPASS-CVOT's kidney outcomes shows greater kidney with tirzepatide (#mounjaro) Glucagon-like Peptide-1 Receptor Agonists and

Description

Here's how you'd build a day from this week's Clean Eatz menu: BREAKFAST Queso Steak Breakfast Bowl 320 cal 24g protein 16g fat 20g carbs LUNCH BBQ Chicken Queso Pasta 359 cal 35g protein 7g fat 39g carbs DINNER Steakhouse Bowl 352 cal 29g protein 8g fat 41g carbs SNACK Dark Chocolate PB Buckeye + Energy Bites (2) ~286 cal ~9g protein ~17g fat ~26g carbs Daily Total ~1,317 cal 97g protein 48g fat 126g carbs Close to target

Can You Take Them Together

Adverse Effects The most common adverse effects are upper respiratory tract infection, nasopharyngitis, and headache

Month 36 What to expect: Consistent weight loss: 410 lbs per month Medication reaches its optimal effect Lifestyle habits have a bigger impact Clothes fit differently Belly fat, back fat, and face puffiness reduce Plateaus may happen, but usually resolve with dosing or nutrition adjustments This is the stage where visible body changes are the most noticeable

Rajesh Kumar, head of European life sciences and healthcare equity research with HSBC, and colleagues upgraded the firms rating on Lilly shares from Reduce to Hold, citing what it called greater clarity on the commercial potential of orforglipron